103.208 articles found

Transcriptome Sequencing Reveals Molecular Characteristics of Spinal Cord Degeneration in MPTP-Induced Parkinson's Disease Mice.

Xiao L, Wu Y, Huang X, Deng H, Wu Y, Pan W, Wang W, Wang M.

Biology (Basel) · 2026-09-02

DOI: 10.3390/biology15171503PMID: 42737935

From Static Stability to Dynamic Gait Governance: Differential Effects of Adapted Physical Activity and Tango-Based Therapy on Walking Distance and Plantar Load Redistribution in Parkinson's Disease.

Marzovillo RRR, D'Orsi G, Vasco P, Cartagena G, Melchionda D, Forte N, Cibelli G, Valenzano AA.

Sports (Basel) · 2026-09-02

DOI: 10.3390/sports14090387PMID: 42784383

Intranasal delivery of cerium oxide nanozyme and superoxide dismutase in exosomes for Parkinson's disease therapy.

Shao X, Li K, Wang Y, He X, Xiong B, Yang S, Li Q.

Mater Today Bio · 2026-09-02

DOI: 10.1016/j.mtbio.2026.103629PMID: 42750983

Neuroprotective effects of chitosan nanoparticle-loaded orientin in a 6-OHDA-induced Parkinson's disease experimental model in rats.

Gelen V, Bayram C, Kara A, Tekiner D, Yeşildağ A.

Neuropharmacology · 2026-09-02

DOI: 10.1016/j.neuropharm.2026.111173PMID: 42685895

A dopaminergic eye–brain correspondence in Parkinson's disease: the substantia-nigra molecular signature localizes to the inner- retinal neurons

Zhang Y, Song W, Yang Y, Zhao M, Yan L.

· 2026-09-01

DOI: 10.21203/rs.3.rs-10422948/v1

Brain Structural Changes Underlying Dysphagia in Parkinson’s Disease: An Exploratory Multimodal Quantitative MRI Study

Krishnamurthy R, Avecillas-Chasin JM, Situ-Kcomt M, Gliske SV.

· 2026-09-01

DOI: 10.21203/rs.3.rs-10882479/v1

Dopaminergic Degeneration and GBA Mutation Status Predict Prior–Sensory Arbitration Disruption in Parkinson's Disease: A Multimodal Computational Framework

Tran K.

· 2026-09-01

DOI: 10.21203/rs.3.rs-10864931/v1

Dysregulated splenic glucocorticoid sensitivity in aging and an α-synuclein transgenic mouse model of Parkinson’s disease

Rombach D, Bopp V, Langgartner D, Grozdanov V, Kassubek J, Touma C, Reber SO, Danzer KM.

· 2026-09-01

DOI: 10.64898/2026.08.27.745197

Convergent Innate Immune and Metabolic Signatures in Parkinson’s Disease and Viral Infection

Belyea M, Shafiq M, Laß J, Much C, Liu Z, Kruse N, Händler K, Sreenivasan V, Gelpi E, Siebels B, Ondruschka B, Spielmann M, Klein C, Trinh J, Glatzel M.

· 2026-09-01

DOI: 10.64898/2026.08.28.26361092

Harmonized Acquisition of Connectome MRI and Clinical Data for Stroke, Parkinson's Disease and Glioma: Delphi‐Derived Protocol Recommendations by the European Academy of Neurology

Berger T, Pini L, Salvalaggio A, Cauzzo S, Klein C, Lolich M, Picca A, Ramankulov D, Rocca M, Rudà R, Sodero A, Tessitore A, Truelsen T, Wiest R, Fink G, Moro E, Ryvlin P, Corbetta M.

European journal of neurology · 2026-09-01

A neuron-distributed DEK integrates ac4C modification and neuroinflammation in pathogenesis of Parkinson disease: evidence from Mendelian randomization, multi-omics and <i>in vitro</i> validation.

Li Y.

Front Neurosci · 2026-09-01

DOI: 10.3389/fnins.2026.1950353PMID: 42745872

Evaluating dispensing patterns of Parkinson's medications from 2012 to 2024 in Australia: insights from the Pharmaceutical Benefits Scheme concessional database.

Shetty S, Park A, Kruger E, Siervo M, Tennant M.

J Prim Health Care · 2026-09-01

DOI: 10.1071/hc25112PMID: 41242879